Comparing two ways to open the left main heart artery
Part of Heart & circulation clinical trials.
This study compares two ways of treating a severe blockage in the left main heart artery, which is the main pipe bringing blood to the whole heart. One way uses a special medicated stent, and the other uses a two-stent approach or a medication-coated balloon to keep the branch open. The goal is to see which method works better for people with this high-risk condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The main blockage must be in the left main heart artery and it must be new (not a re-blockage).
- The blockage must also involve the first branch off the left main, called the circumflex artery, and that branch must be properly prepared before stenting.
- The doctor must believe it's safe to treat the branch either with a drug-eluting stent (a medicated mesh tube) or a drug-coated balloon (a balloon that delivers medication).
- You must be clinically stable at the time of the procedure.
- You must be able to take dual antiplatelet therapy (two blood-thinning medicines) for at least a year after the procedure.
- You must be willing to commit to 2 years of follow-up after the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of placing a stent at the point where the main left artery splits into two branches. It is for people who have a blockage in the very beginning of one of those branches, and it uses advanced drug-eluting stents to see which method works better.
This trial studies a new way to treat blockages in the left main coronary artery using a drug-coated stent. It aims to find out if a careful approach with a single stent and temporary side-branch support works well for people with heart disease.
This study tests whether using a drug-coated balloon alongside a stent improves outcomes for people with a blockage in the left main coronary artery, the main artery supplying the heart. It compares this approach to standard stenting, aiming to reduce re-blockage risk.
This trial compares two ways to treat a coronary artery blockage at a fork (bifurcation): one uses a standard stent, the other uses a special balloon that releases medication to keep the artery open. It aims to find which approach is safer and more effective for patients with this specific type of blockage.
This study tests a new type of heart stent against a special balloon treatment for people with a large, newly blocked heart artery. The goal is to see which treatment is safer and works better at keeping the artery open.
This study compares two different ways of placing two drug-eluting stents for new (de novo) coronary artery blockages that split into two branches. It may help doctors choose the safest, most effective technique for patients with specific coronary anatomy.
Hear when a new Unprotected Left Main Coronary Artery Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.